Aptus® Felilysin Solution 50 ml
- Reviews 2
- Help and manuals
- Ingredient
- Specifications
- Photos & Videos 1
- Alternatives 8
- Accessories and suggested products
Aptus® Felilysin Solution 50 ml
Aptus Felilysin is a solution containing L-lysine, which supports the immune system of cats. The product is recommended for the prevention and treatment of feline herpesvirus-1 (FHV-1). L-lysine is a vital amino acid for cats that their bodies cannot produce naturally, so it must be included in their diet or as a supplement to ensure overall health and immunity. Each milliliter contains 263 mg of L-lysine and the recommended daily dose is 263-526 mg of L-lysine. The solution can be used daily or as needed. Aptus Felilysin is an L-lysine supplement in solution form for cats to support their overall health and immunity. It is recommended as an essential lysine supplement for cats to ensure proper function of their immune system.
Key features of Aptus® Felilysin Solution, 50 ml
- Solution containing L-lysine for cats
- Supports the immune system and overall health of cats
- Helps prevent and treat feline herpesvirus-1 (FHV-1)
- L-lysine is an essential amino acid that cats cannot produce themselves
- Each millilitre contains 263 mg of L-lysine
- The recommended daily dose contains 263-526 mg of L-lysine
- Can be used daily or as needed
- Ensures proper immunity and health support for cats
Feeding instructions
The recommended daily dose for a cat is 1-2 ml of the solution. The solution can be mixed with food. Measure the recommended daily dose with the applicator and then mix it into your food. Don't touch anything with an eyedropper.
Storage:
Store at room temperature (15-25 °C). Use within 2 months of opening. Keep out of reach and sight of children and animals.
Specifications
Plush Toy
Packaging
Type
Orion Pharma s.r.o. Na Strži 2102/61a, Praha 14000, Česká republika, +420234703305, [email protected], www.orionpharmaanimalhealth.com
Specifications can be changed without notice. Images are for illustrative purposes only.
